649
Views
33
CrossRef citations to date
0
Altmetric
Invited Review

Reticular pseudodrusen: current understanding

, MD BSc & , MBBS PhD FRANZCO FAAHMS
Pages 455-462 | Received 15 Apr 2018, Accepted 28 Aug 2018, Published online: 15 Apr 2021

REFERENCES

  • Bressler NM. Age‐related macular degeneration is the leading cause of blindness. JAMA 2004; 291: 1900–1901.
  • Lim LS, Mitchell P, Seddon JM et al. Age‐related macular degeneration. Lancet 2012; 379: 1728–1738.
  • Mimoun G, Soubrane G, Coscas G. Macular drusen. J Fr Ophtalmol 1990; 13: 511–530.
  • Finger RP, Wu Z, Luu CD et al. Reticular pseudodrusen: a risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization. Ophthalmology 2014; 121: 1252–1256.
  • Klein R, Klein BEK, Knudtson MD et al. Fifteen‐year cumulative incidence of age‐related macular degeneration: the beaver dam eye study. Ophthalmology 2007; 114: 253–262.
  • Joachim N, Mitchell P, Rochtchina E et al. Incidence and progression of reticular drusen in age‐related macular degeneration: findings from an older Australian cohort. Ophthalmology 2014; 121: 917–925.
  • Pumariega NM, Smith RT, Sohrab MA et al. A prospective study of reticular macular disease. Ophthalmology 2011; 118: 1619–1625.
  • Arnold JJ, Sarks SH, Killingsworth MC et al. Reticular pseudodrusen. A risk factor in age‐related maculopathy. Retina 1995; 15: 183–191.
  • Rudolf M, Malek G, Messinger JD et al. Sub‐retinal drusenoid deposits in human retina: organization and composition. Exp Eye Res 2008; 87: 402–408.
  • Wang JJ, Rochtchina E, Lee AJ et al. Ten‐year incidence and progression of age‐related maculopathy: the Blue Mountains eye study. Ophthalmology 2007; 114: 92–98.
  • Zweifel SA, Spaide RF, Curcio CA et al. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010; 117: 303–312.e301.
  • Smith RT, Sohrab MA, Busuioc M et al. Reticular macular disease. Am J Ophthalmol 2009; 148: 733–743.e732.
  • Schmitz‐valckenberg S, Alten F, Steinberg JS et al. Reticular drusen associated with geographic atrophy in age‐related macular degeneration. Invest Ophthalmol Vis Sci 2011; 52: 5009–5015.
  • Gliem M, Hendig D, Finger RP et al. Reticular pseudodrusen associated with a diseased bruch membrane in pseudoxanthoma elasticum. JAMA Ophthalmol 2015; 133: 581–588.
  • Genead MA, Fishman GA, Lindeman M. Spectral‐domain optical coherence tomography and fundus autofluorescence characteristics in patients with fundus albipunctatus and retinitis punctata albescens. Ophthalmic Genet 2010; 31: 66–72.
  • Gliem M, Müller PL, Mangold E et al. Reticular pseudodrusen in sorsby fundus dystrophy. Ophthalmology 2015; 122: 1555–1562.
  • Wilde C, Lakshmanan A, Patel M et al. Prevalence of reticular pseudodrusen in newly presenting adult onset foveomacular vitelliform dystrophy. Eye 2016; 30: 817–824.
  • Cohen SY, Dubois L, Tadayoni R et al. Prevalence of reticular pseudodrusen in age‐related macular degeneration with newly diagnosed choroidal neovascularisation. Br J Ophthalmol 2007; 91: 354–359.
  • Zarubina AV, Neely DC, Clark ME et al. Prevalence of subretinal Drusenoid deposits in older in persons with and without age‐related macular degeneration, by multimodal imaging. Ophthalmology 2016; 123: 1090–1100.
  • Chan H, Cougnard‐grégoire A, Delyfer M‐N et al. Multimodal imaging of reticular Pseudodrusen in a population‐based setting: the Alienor study. Invest Ophthalmol Vis Sci 2016; 57: 3058–3065.
  • Klein R, Meuer SM, Knudtson MD et al. The epidemiology of retinal reticular drusen. Am J Ophthalmol 2008; 145: 317–326.e311.
  • Ueda‐arakawa N, Ooto S, Tsujikawa A et al. Sensitivity and specificity of detecting reticular pseudodrusen in multimodal imaging in Japanese patients. Retina 2013; 33: 490–497.
  • Yun C, Oh J, Ahn SE et al. Peripapillary choroidal thickness in patients with early age‐related macular degeneration and reticular pseudodrusen. Graefes Arch Clin Exp Ophthalmol 2016; 254: 427–435.
  • Finger RP, Chong E, Mcguinness MB et al. Reticular pseudodrusen and their association with age‐related macular degeneration: the Melbourne Collaborative Cohort Study. Ophthalmology 2016; 123: 599–608.
  • Wu Z, Ayton LN, Luu CD et al. Reticular Pseudodrusen in intermediate age‐related macular degeneration: prevalence, detection, clinical, environmental, and genetic associations. Invest Ophthalmol Vis Sci 2016; 57: 1310–1316.
  • Zweifel SA, Imamura Y, Spaide TC et al. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age‐related macular degeneration. Ophthalmology 2010; 117: 1775–1781.
  • Marsiglia M, Boddu S, Bearelly S et al. Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age‐related macular degeneration. Invest Ophthalmol Vis Sci 2013; 54: 7362–7369.
  • Neely D, Zarubina AV, Clark ME et al. Association between visual function and subretinal drusenoid deposits in normal and early age‐related macular degeneration eyes. Retina 2017; 37: 1329–1336.
  • Sarks J, Arnold J, Ho IV et al. Evolution of reticular pseudodrusen. Br J Ophthalmol 2011; 95: 979–985.
  • Hogg RE. Reticular pseudodrusen in age‐related macular degeneration. Optom Vis Sci 2014; 91: 854–859.
  • Wilde C, Patel M, Lakshmanan A et al. Prevalence of reticular pseudodrusen in eyes with newly presenting neovascular age‐related macular degeneration. Eur J Ophthalmol 2016; 26: 128–134.
  • Nghiem‐buffet S, Giocanti‐auregan A, Jung C et al. Reticular pseudodrusen are not a predictive factor for the 1‐year response to intravitreal ranibizumab in neovascular age‐related macular degeneration. Retina 2017; 37: 53–59.
  • Mantel I, Dirani A, Zola M et al. Macular atrophy incidence in anti‐vascular endothelial growth factor‐treated neovascular age‐related macular degneration: risk factor evaluation for individualized treatment need of ranibizumab or aflibercept according to an observe‐and‐plan regimen. Retina 2018; https://doi.org/10.1097/IAE.0000000000002054.
  • Spaide RF. Outer retinal atrophy after regression of subretinal drusenoid deposits as a newly recognized form of late age‐related macular degeneration. Retina 2013; 33: 1800–1808.
  • Cicinelli MV, Rabiolo A, Sacconi R et al. Retinal vascular alterations in reticular pseudodrusen with and without outer retinal atrophy assessed by optical coherence tomography angiography. Br J Ophthalmol 2018; 102: 1192–1198.
  • Greferath U, Guymer RH, Vessey KA et al. Correlation of histologic features with in vivo imaging of reticular Pseudodrusen. Ophthalmology 2016; 123: 1320–1331.
  • Zweifel SA, Spaide RF, Yannuzzi LA. Acquired vitelliform detachment in patients with subretinal drusenoid deposits (reticular pseudodrusen). Retina 2011; 31: 229–234.
  • Weber BH, Vogt G, Pruett RC et al. Mutations in the tissue inhibitor of metalloproteinases‐3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 1994; 8: 352–356.
  • Gliem M, Zaeytijd JD, Finger RP et al. An update on the ocular phenotype in patients with pseudoxanthoma elasticum. Front Genet 2013; 4: 14.
  • Chassaing N, Martin L, Calvas P et al. Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet 2005; 42: 881–892.
  • Lally DR, Baumal C. Subretinal drusenoid deposits associated with complement‐mediated IgA nephropathy. JAMA Ophthalmol 2014; 132: 775–777.
  • Aleman TS, Garrity ST, Brucker AJ. Retinal structure in vitamin A deficiency as explored with multimodal imaging. Doc Ophthalmol 2013; 127: 239–243.
  • Cukras C, Flamendorf J, Wong WT et al. Longitudinal structural changes in late‐onset retinal degeneration. Retina 2016; 36: 2348–2356.
  • Klein R, Davis MD, Magli YL et al. The Wisconsin age‐related maculopathy grading system. Ophthalmology 1991; 98: 1128–1134.
  • De bats F, Mathis T, Mauget‐faysse M et al. Prevalence of reticular pseudodrusen in age‐related macular degeneration using multimodal imaging. Retina 2016; 36: 46–52.
  • Querques G, Canoui‐poitrine F, Coscas F et al. Analysis of progression of reticular pseudodrusen by spectral domain‐optical coherence tomography. Invest Ophthalmol Vis Sci 2012; 53: 1264–1270.
  • Suzuki M, Sato T, Spaide RF. Pseudodrusen subtypes as delineated by multimodal imaging of the fundus. Am J Ophthalmol 2014; 157: 1005–1012.
  • Curcio CA, Messinger JD, Sloan KR et al. Subretinal drusenoid deposits in non‐neovascular age‐related macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina 2013; 33: 265–276.
  • Bindewald A, Bird AC, Dandekar SS et al. Classification of fundus autofluorescence patterns in early age‐related macular disease. Invest Ophthalmol Vis Sci 2005; 46: 3309–3314.
  • Delori FC, Goger DG, Dorey CK. Age‐related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci 2001; 42: 1855–1866.
  • Steinberg JS, Auge J, Jaffe GJ et al. Longitudinal analysis of reticular Drusen associated with geographic atrophy in age‐related macular degeneration. Invest Ophthalmol Vis Sci 2013; 54: 4054–4060.
  • Witmer MT, Andrzej K, Daniel S et al. Peripheral autofluorescence findings in age‐related macular degeneration. Acta Ophthalmol 2012; 90: e428–e433.
  • Domalpally A, Clemons TE, Danis RP et al. Peripheral retinal changes associated with age‐related macular degeneration in the age‐related eye disease study 2: age‐related eye disease study 2 report number 12 by the age‐related eye disease study 2 Optos PEripheral RetinA (OPERA) study research group. Ophthalmology 2017; 124: 479–487.
  • Rabiolo A, Sacconi R, Cicinelli MV et al. Spotlight on reticular pseudodrusen. Clin Ophthalmol 2017; 11: 1707–1718.
  • Querques G, Querques L, Martinelli D et al. Pathologic insights from integrated imaging of reticular pseudodrusen in age‐related macular degeneration. Retina 2011; 31: 518–526.
  • Arnold JJ, Quaranta M, Soubrane G et al. Indocyanine green angiography of Drusen. Am J Ophthalmol 1997; 124: 344–356.
  • Schaal KB, Legarreta AD, Feuer WJ et al. Comparison between Widefield En face swept‐source OCT and conventional multimodal imaging for the detection of reticular Pseudodrusen. Ophthalmology 2017; 124: 205–214.
  • Paavo M, Lee W, Merriam J et al. Intraretinal correlates of reticular Pseudodrusen revealed by autofluorescence and En face OCT. Invest Ophthalmol Vis Sci 2017; 58: 4769–4777.
  • Querques G, Kamami‐levy C, Blanco‐garavito R et al. Appearance of medium–large drusen and reticular pseudodrusen on adaptive optics in age‐related macular degeneration. Br J Ophthalmol 2014; 98: 1522–1527.
  • Zhang Y, Wang X, Rivero EB et al. Photoreceptor perturbation around subretinal drusenoid deposits as revealed by adaptive optics scanning laser ophthalmoscopy. Am J Ophthalmol 2014; 158: 584–596.e581.
  • Badal J, Biarnes M, Mones J. Performance characteristics of multicolor versus blue light and infrared imaging in the identification of reticular pseudodrusen. Int Ophthalmol 2018; 38: 199–206.
  • Paulus TVMJ. A historical analysis of the quest for the origins of aging macula disorder, the tissues involved, and its terminology: supplementary issue: ophthalmic history. Ophthalmol Eye Dis 2016; 8s1(Suppl 1): 5–14.
  • Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, 2nd ed. St. Louis, MO: Mosby, 1977.
  • Russell SR, Mullins RF, Schneider BL et al. Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age‐related macular degeneration. Am J Ophthalmol 2000; 129: 205–214.
  • Querques G, Querques L, Forte R et al. Choroidal changes associated with reticular pseudodrusen. Invest Ophthalmol Vis Sci 2012; 53: 1258–1263.
  • Garg A, Oll M, Yzer S et al. Reticular pseudodrusen in early age‐related macular degeneration are associated with choroidal thinning. Invest Ophthalmol Vis Sci 2013; 54: 7075–7081.
  • Ho CYD, Lek JJ, Aung KZ et al. Relationship between reticular pseudodrusen and choroidal thickness in intermediate age‐related macular degeneration. Clin Exp Ophthalmol 2018; 46: 485–494.
  • Oak AS, Messinger JD, Curcio CA. Subretinal drusenoid deposits: further characterization by lipid histochemistry. Retina 2014; 34: 825–826.
  • Vessey KA, Wilkinson‐berka JL, Fletcher EL. Characterization of retinal function and glial cell response in a mouse model of oxygen‐induced retinopathy. J Comp Neurol 2011; 519: 506–527.
  • Longbottom R, Fruttiger M, Douglas RH et al. Genetic ablation of retinal pigment epithelial cells reveals the adaptive response of the epithelium and impact on photoreceptors. Proc Natl Acad Sci U S A 2009; 106: 18728–18733.
  • Fraser RG, Tan R, Ayton LN et al. Assessment of retinotopic rod photoreceptor function using a dark‐adapted chromatic perimeter in intermediate age‐related macular degeneration. Invest Ophthalmol Vis Sci 2016; 57: 5436–5442.
  • Flamendorf J, Agron E, Wong WT et al. Impairments in dark adaptation are associated with age‐related macular degeneration severity and reticular Pseudodrusen. Ophthalmology 2015; 122: 2053–2062.
  • Wu Z, Ayton LN, Makeyeva G et al. Impact of reticular Pseudodrusen on microperimetry and multifocal electroretinography in intermediate age‐related macular degeneration. Invest Ophthalmol Vis Sci 2015; 56: 2100–2106.
  • Steinberg JS, Fitzke FW, Fimmers R et al. Scotopic and photopic microperimetry in patients with reticular drusen and age‐related macular degeneration. JAMA Ophthalmol 2015; 133: 690–697.
  • Querques G, Massamba N, Srour M et al. Impact of reticular pseudodrusen on macular function. Retina 2014; 34: 321–329.
  • Vemala R, Sivaprasad S, Barbur JL. Detection of early loss of color vision in age‐related macular degeneration – with emphasis on Drusen and reticular Pseudodrusen. Invest Ophthalmol Vis Sci 2017; 58: BIO247–BIO254.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.